Statin Use is Associated with Improved Outcomes of Patients With Primary Sclerosing Cholangitis

There is increasing evidence that statins can benefit patients with chronic liver diseases, but their effects have not been studied in patients with primary sclerosing cholangitis (PSC). We performed a nationwide study in Sweden to determine the effects of exposure to drugs, including statins, in patients with PSC.

Source: Clinical Gastroenterology and Hepatology - November 15, 2018 Category: Gastroenterology Authors: Knut Stokkeland, Jonas H öijer, Matteo Bottai, Karin Söderberg-Löfdal, Annika Bergquist Source Type: research